Dow Up 0.43% Nasdaq Up 0.20%

Celsion Corporation (CLSN)

-NasdaqCM
0.23 Down 0.02(6.96%) 1:54PM EST - Nasdaq Real Time Price
Prev Close:0.25
Open:0.27
Bid:0.23 x 200
Ask:0.23 x 700
1y Target Est:3.00
Beta:1.75346
Earnings Date:Mar 28 - Apr 3 (Est.)
Day's Range:0.23 - 0.27
52wk Range:0.19 - 1.78
Volume:3,330,634
Avg Vol (3m):1,604,690
Market Cap:7.26M
P/E (ttm):N/A
EPS (ttm):-0.90
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for CLSN

Comparison

Symbol% ChgMkt Cap
CLSNDown 6.96%7.26M
MMSIDown 0.53%1.25B
BSDM 0.00%N/A
DCTHUp 20.89%3.46M

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):13.04
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-16) :-0.85
Quarterly EPS Est (Dec-16) :-0.19
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Celsion Corporation, an oncology drug development company, focuses on the development and commercialization of chemotherapeutic oncology drugs based on its proprietary heat-activated liposomal technology. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback